Pfeil Keith W

Director, President, CEO, COO, CFO, SVP, Chief Financial Officer, Exec. VP and CFO · SEC CIK 1752014
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$6.21M
9 trades
Net flow
−$6.21M
Net selling
Total filings
24
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
GMED
Sell Pfeil Keith W · COO, CFO · Open-market sale · filed Jan 14, 2025 ΔOwn −88%

Pfeil Keith W sold $1.1M of GMED, trimming their stake 88%.

−$1.1M
12,501 sh @ $88
GMED
Sell Pfeil Keith W · COO, CFO · Open-market sale · filed Jan 14, 2025 ΔOwn −100%

Pfeil Keith W sold $148.6K of GMED, trimming their stake 100%.

−$148.6K
1,666 sh @ $89
GMED
Option exercise Pfeil Keith W · SVP, Chief Financial Officer · Option exercise · filed Feb 6, 2023 ΔOwn NEW
+$703.4K
14,167 sh @ $50
Advertisement
GMED
Option exercise Pfeil Keith W · SVP, Chief Financial Officer · Option exercise · filed Feb 6, 2023 ΔOwn +106%
+$799.1K
15,000 sh @ $53
GMED
Sell Pfeil Keith W · SVP, Chief Financial Officer · Open-market sale · filed Feb 6, 2023 ΔOwn −100%

Pfeil Keith W sold $2.26M of GMED, trimming their stake 100%.

−$2.26M
29,167 sh @ $78
GMED
Option exercise Pfeil Keith W · SVP, Chief Financial Officer · Option exercise · filed Aug 23, 2021 ΔOwn NEW
+$44.4K
833 sh @ $53
GMED
Sell Pfeil Keith W · SVP, Chief Financial Officer · Open-market sale · filed Aug 23, 2021 ΔOwn −100%

Pfeil Keith W sold $63.4K of GMED, trimming their stake 100%.

−$63.4K
833 sh @ $76
GMED
Option exercise Pfeil Keith W · SVP, Chief Financial Officer · Option exercise · filed Aug 3, 2021 ΔOwn NEW
+$44.4K
833 sh @ $53
GMED
Sell Pfeil Keith W · SVP, Chief Financial Officer · Open-market sale · filed Aug 3, 2021 ΔOwn −100%

Pfeil Keith W sold $69.3K of GMED, trimming their stake 100%.

−$69.3K
833 sh @ $83
GMED
Option exercise Pfeil Keith W · SVP, Chief Financial Officer · Option exercise · filed Jul 20, 2021 ΔOwn NEW
+$41.4K
834 sh @ $50
GMED
Sell Pfeil Keith W · SVP, Chief Financial Officer · Open-market sale · filed Jul 20, 2021 ΔOwn −100%

Pfeil Keith W sold $65.3K of GMED, trimming their stake 100%.

−$65.3K
834 sh @ $78
GMED
Option exercise Pfeil Keith W · SVP, Chief Financial Officer · Option exercise · filed Jul 6, 2021 ΔOwn NEW
+$44.4K
833 sh @ $53
GMED
Sell Pfeil Keith W · SVP, Chief Financial Officer · Open-market sale · filed Jul 6, 2021 ΔOwn −100%

Pfeil Keith W sold $64.5K of GMED, trimming their stake 100%.

−$64.5K
833 sh @ $77
GMED
Option exercise Pfeil Keith W · SVP, Chief Financial Officer · Option exercise · filed Jun 28, 2021 ΔOwn NEW
+$660.9K
13,312 sh @ $50
GMED
Option exercise Pfeil Keith W · SVP, Chief Financial Officer · Option exercise · filed Jun 28, 2021 ΔOwn NEW
+$754.7K
14,167 sh @ $53
GMED
Sell Pfeil Keith W · SVP, Chief Financial Officer · Open-market sale · filed Jun 28, 2021 ΔOwn −100%

Pfeil Keith W sold $2.06M of GMED, trimming their stake 100%.

−$2.06M
27,479 sh @ $75
GMED
Option exercise Pfeil Keith W · SVP, Chief Financial Officer · Option exercise · filed May 7, 2021 ΔOwn NEW
+$249.3K
5,021 sh @ $50
GMED
Sell Pfeil Keith W · SVP, Chief Financial Officer · Open-market sale · filed May 7, 2021 ΔOwn −100%

Pfeil Keith W sold $376.6K of GMED, trimming their stake 100%.

−$376.6K
5,021 sh @ $75

Frequently asked questions

How is Pfeil Keith W's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Pfeil Keith W's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.